Global Phage Therapy Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Phage Therapy market size will reach 128.92 Million USD in 2025 and is projected to reach 612.68 Million USD by 2032, with a CAGR of 24.94% (2025-2032). Notably, the China Phage Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Phage therapy is a form of medical treatment that utilizes bacteriophages, which are viruses that infect and kill bacteria, to combat bacterial infections in humans or animals. Bacteriophages are highly specific to particular strains of bacteria, allowing for targeted and precise treatment. In phage therapy, specific phages are selected to match the infectious bacteria, and these phages are then administered to the patient, typically in the form of a phage cocktail. The phages infect and replicate within the bacterial cells, ultimately leading to the destruction of the bacteria. Phage therapy has been explored as an alternative or complementary approach to antibiotics, particularly in cases where antibiotic resistance poses a challenge. While phage therapy has shown promise, it is still an evolving field, and further research is needed to establish its safety and efficacy for widespread clinical use.
The major global suppliers of Phage Therapy include BiomX (Adaptive Phage Therapeutics), Armata Pharmaceuticals, Phaxiam, Locus, Biosciences, Inc, TechnoPhage, NPO Microgen, MicroMir, Biochimpharm, iNtRON Biotechnology, PrecisioBiotix, Eliava BioPreparations, Intralytix, NexaBiome, CreatiPhage, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Phage Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Phage Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Phage Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Phage Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Phage Therapy Include:
BiomX (Adaptive Phage Therapeutics)
Armata Pharmaceuticals
Phaxiam
Locus
Biosciences, Inc
TechnoPhage
NPO Microgen
MicroMir
Biochimpharm
iNtRON Biotechnology
PrecisioBiotix
Eliava BioPreparations
Intralytix
NexaBiome
CreatiPhage
Phage Therapy Product Segment Include:
Natural Phages
Synthetic Phages
Phage Therapy Product Application Include:
Animal Health
Human Health
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Phage Therapy Industry PESTEL Analysis
Chapter 3: Global Phage Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Phage Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Phage Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Phage Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Phage Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Phage Therapy market size will reach 128.92 Million USD in 2025 and is projected to reach 612.68 Million USD by 2032, with a CAGR of 24.94% (2025-2032). Notably, the China Phage Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Phage therapy is a form of medical treatment that utilizes bacteriophages, which are viruses that infect and kill bacteria, to combat bacterial infections in humans or animals. Bacteriophages are highly specific to particular strains of bacteria, allowing for targeted and precise treatment. In phage therapy, specific phages are selected to match the infectious bacteria, and these phages are then administered to the patient, typically in the form of a phage cocktail. The phages infect and replicate within the bacterial cells, ultimately leading to the destruction of the bacteria. Phage therapy has been explored as an alternative or complementary approach to antibiotics, particularly in cases where antibiotic resistance poses a challenge. While phage therapy has shown promise, it is still an evolving field, and further research is needed to establish its safety and efficacy for widespread clinical use.
The major global suppliers of Phage Therapy include BiomX (Adaptive Phage Therapeutics), Armata Pharmaceuticals, Phaxiam, Locus, Biosciences, Inc, TechnoPhage, NPO Microgen, MicroMir, Biochimpharm, iNtRON Biotechnology, PrecisioBiotix, Eliava BioPreparations, Intralytix, NexaBiome, CreatiPhage, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Phage Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Phage Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Phage Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Phage Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Phage Therapy Include:
BiomX (Adaptive Phage Therapeutics)
Armata Pharmaceuticals
Phaxiam
Locus
Biosciences, Inc
TechnoPhage
NPO Microgen
MicroMir
Biochimpharm
iNtRON Biotechnology
PrecisioBiotix
Eliava BioPreparations
Intralytix
NexaBiome
CreatiPhage
Phage Therapy Product Segment Include:
Natural Phages
Synthetic Phages
Phage Therapy Product Application Include:
Animal Health
Human Health
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Phage Therapy Industry PESTEL Analysis
Chapter 3: Global Phage Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Phage Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Phage Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Phage Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Phage Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Phage Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Phage Therapy Product by Type
- 1.2.1 Natural Phages
- 1.2.2 Synthetic Phages
- 1.3 Phage Therapy Product by Application
- 1.3.1 Animal Health
- 1.3.2 Human Health
- 1.4 Global Phage Therapy Market Size Analysis (2020-2032)
- 1.5 Phage Therapy Market Development Status and Trends
- 1.5.1 Phage Therapy Industry Development Status Analysis
- 1.5.2 Phage Therapy Industry Development Trends Analysis
- 2 Phage Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Phage Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Phage Therapy Market Analysis by Country
- 4.1 Global Phage Therapy Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Phage Therapy Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Phage Therapy Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.5 China Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.6 France Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.14 India Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Phage Therapy Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Phage Therapy Market Revenue by Key Suppliers (2021-2025)
- 5.2 Phage Therapy Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Phage Therapy Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Phage Therapy Market Analysis by Type
- 6.1 Global Phage Therapy Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Phage Therapy Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 BiomX (Adaptive Phage Therapeutics)
- 7.1.1 BiomX (Adaptive Phage Therapeutics) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 BiomX (Adaptive Phage Therapeutics) Phage Therapy Product Portfolio
- 7.1.3 BiomX (Adaptive Phage Therapeutics) Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Armata Pharmaceuticals
- 7.2.1 Armata Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Armata Pharmaceuticals Phage Therapy Product Portfolio
- 7.2.3 Armata Pharmaceuticals Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Phaxiam
- 7.3.1 Phaxiam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Phaxiam Phage Therapy Product Portfolio
- 7.3.3 Phaxiam Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Locus
- 7.4.1 Locus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Locus Phage Therapy Product Portfolio
- 7.4.3 Locus Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Biosciences, Inc
- 7.5.1 Biosciences, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Biosciences, Inc Phage Therapy Product Portfolio
- 7.5.3 Biosciences, Inc Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 TechnoPhage
- 7.6.1 TechnoPhage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 TechnoPhage Phage Therapy Product Portfolio
- 7.6.3 TechnoPhage Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 NPO Microgen
- 7.7.1 NPO Microgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 NPO Microgen Phage Therapy Product Portfolio
- 7.7.3 NPO Microgen Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 MicroMir
- 7.8.1 MicroMir Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 MicroMir Phage Therapy Product Portfolio
- 7.8.3 MicroMir Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Biochimpharm
- 7.9.1 Biochimpharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Biochimpharm Phage Therapy Product Portfolio
- 7.9.3 Biochimpharm Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 iNtRON Biotechnology
- 7.10.1 iNtRON Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 iNtRON Biotechnology Phage Therapy Product Portfolio
- 7.10.3 iNtRON Biotechnology Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 PrecisioBiotix
- 7.11.1 PrecisioBiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 PrecisioBiotix Phage Therapy Product Portfolio
- 7.11.3 PrecisioBiotix Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Eliava BioPreparations
- 7.12.1 Eliava BioPreparations Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Eliava BioPreparations Phage Therapy Product Portfolio
- 7.12.3 Eliava BioPreparations Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Intralytix
- 7.13.1 Intralytix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Intralytix Phage Therapy Product Portfolio
- 7.13.3 Intralytix Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 NexaBiome
- 7.14.1 NexaBiome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 NexaBiome Phage Therapy Product Portfolio
- 7.14.3 NexaBiome Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 CreatiPhage
- 7.15.1 CreatiPhage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 CreatiPhage Phage Therapy Product Portfolio
- 7.15.3 CreatiPhage Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Phage Therapy Industry Chain Analy
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
